Peptide record

TPDB24268

PFV PTD Tf-PFV PF4 Antibacterial Antiviral Blood-Brain Barrier Cell-penetrating Peptides standard
6 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB24268
PFV PTD Tf-PFV PF4
Antibacterial Antiviral Blood-Brain Barrier Cell-penetrating Peptides
Anti-infective peptides Delivery and barrier-penetrating peptides
Peptipedia dbAMP 3.0 DRAVP 2.0 B3Pred BBPpredict CellPPD CellPPD-MOD CPPsite3.0 MLCPP 2.0 PerseuCPP
standard
No
A 6-aa standard-residue multi-activity (Antibacterial, Antiviral, Blood-Brain Barrier, and other sources) peptide sequence curated from Peptipedia, dbAMP 3.0, DRAVP 2.0, and other sources, with an available 3D structural model.
Sequence
PFVYLI
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C40H58N6O8
ARNDCEQGHKMSTW
ILFPYV
750.94
5.94
0
0
5
-0
-2.79
2.067
178.33
Mammalian: >20 hour Yeast: >20 hour E.coli: ?
1490
1.98
1
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
1
I
1
L
0
K
0
M
1
F
1
P
0
S
0
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 1 K: 0 M: 0 F: 1 P: 1 S: 0 T: 0 W: 0 Y: 1 V: 1
Chemical Descriptors
6 reviewed residue count
C40H58N6O8 sequence-only estimate (linear, free termini)
750.94 sequence-only estimate (linear, free termini)
5.94 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
-2.79 sequence-only estimate (linear, free termini)
2.067 sequence-only estimate (linear, free termini)
Free Activity
L Activity
Linear Activity
Neutral Hydrophobic Activity
Linear Activity
Free Activity
Cationic Activity
ProPheValTyrLeuIle Activity
N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)O N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC1=NC=NC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O Activity
Evidence Records 5 records
Evidence 1 Activity

Activity

Blood-Brain Barrier

Target

Glioblastoma (U87), brain endothelial (bEnd.3), an

Assay & Model

By measuring the flux of sodium fluorescence (Na-F) and TEER
The transport of Tf-PFV liposomes across the endothelial barrier layer into tumor grown in the porou
Glioblastoma multiforme

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
The dual functionalized liposomes showed significantly higher cellular uptake as well as increased t
Transcytosis
Combination with the transferrin protein
Evidence 2 Activity

Activity

Cell-penetrating Peptides

Target

MCF-7, HeLa, Hepg2 And MCF-7/Adr Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Natural residues Linear L Neutral
Synthetic
Cytosol
CsA internalization was 4.7-fold higher for PFV and 6.8-fold higher for VPT in HeLa cells 5.6-fold higher for PFV and 19.1-fold higher for VPT in MCF-7 cells
In vitro
CCCCCC
Evidence 3 Activity

Activity

Cell-penetrating Peptides

Target

K-562 ,Sco2/Cox-Deficient Fibroblasts, Bm-Nucleated Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L
Synthetic
IVT-mRNA of SCO2 and β-globin
Efficient delivery of PTD-IVT-mRNA of SCO2 was confirmed in 30 min
Clathrin mediated endocytosis
In vitro
CCGGGTSCC
Evidence 4 Activity

Activity

Cell-penetrating Peptides

Target

MCF-7

Assay & Model

Female BALB/c nude mice of 18–20 g
Female BALB/c nude mice of 18–20 g

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Hydrophobic
Protein derived
Cou6-nanoliposomes loaded paclitaxel (PTX)
Cytoplasm
Cou6 level for PFV-Lip-Cou6 was 2.3-fold higher than that of Lip-Cou6
In vitro and in vivo
CCCCSHHHHTTSCCCCSSCCCSCC
Evidence 5 Activity

Activity

Cell-penetrating Peptides

Target

HeLa Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Non-natural residues Linear L Hydrophobic
Protein derived
pHPMA polymer
Cytoplasm
About 4 to 5 times higher concentration than the control polymer REF
Endocytosis
In vitro
Additional Detail Fields 1 fields
CCCCCC CCGGGTSCC CCCCSHHHHTTSCCCCSSCCCSCC